Recent Announcements

SANUWAVE Technology Shown to Successfully Treat Nonunion Fractures of the Tibia

SANUWAVE's President and CEO, Christopher M. Cashman, to Present at ROTH Capital Partners 22nd Annual OC Growth Stock Conference on March 17, 2010

PACE™ Reported to Heal Severe Burns without Surgery or Skin Grafting - U.S. Clinical Trial Expected, and European Distribution Partnerships Planned

Dr. Maria Siemionow, World Renowned Plastic Surgeon, Joins SANUWAVE's Scientific Advisory Board. . . .SANUWAVE's PACE™ Technology Shows Improved Skin Flap Survival Rates In Peer Reviewed Journal Article. . . .Dr. Maria Siemionow, World Renowned Plastic Surgeon, Joins SANUWAVE's Scientific Advisory Board. . . .SANUWAVE Health To Present At Sidoti & Company's Micro Cap Conference On January 11, 2010. . . .

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures.

SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body's normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.